Hypoxia as a target for combined modality treatments
- 1 January 2002
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (2), 240-257
- https://doi.org/10.1016/s0959-8049(01)00361-6
Abstract
No abstract availableKeywords
This publication has 207 references indexed in Scilit:
- Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapyGene Therapy, 2001
- Vascular targeting of solid tumours: a major ‘inverse’ volume–response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomasEuropean Journal Of Cancer, 2000
- Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasisBritish Journal of Cancer, 2000
- Matrix metalloproteinasesEuropean Journal Of Cancer, 2000
- Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activitiesOncogene, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Vinca alkaloids: Anti-vascular effects in a murine tumourEuropean Journal Of Cancer, 1993
- Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: Evidence for a vascular mechanismEuropean Journal of Cancer and Clinical Oncology, 1991
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989